The Drinkers ’ Intervention to Prevent Tuberculosis (DIPT) trial among heavy drinkers living with HIV in Uganda: study protocol of a 2×2 factorial trial
This study will provide new information on low-cost strategies to both reduce alcohol use and increase INH adherence among people with HIV and TB infection who engage in heavy drinking in low-income countries with high HIV and TB prevalence.Trial registrationClinicalTrials.govNCT03492216. Registered on April 10, 2018 (Source: Trials)
Source: Trials - May 20, 2021 Category: Research Source Type: clinical trials

Evaluation of the Safety, Tolerability, PK of TBAJ-587 in Healthy Adults
Condition:   Tuberculosis Interventions:   Drug: Part 1 Dose Level 1: 25 mg TBAJ-587;   Drug: Part 1 Dose Level 1: TBAJ-587 placebo oral suspension;   Drug: Part 1 Dose Level 2: 50 mg TBAJ-587;   Drug: Part 1 Dose Level 2: TBAJ-587 placebo;   Drug: Part 1 Dose Level 3: 100 mg TBAJ-587;   Drug: Part 1  Dose Level 3: TBAJ-587 placebo;   Drug: Part 1 Dose Level 4: 200&nb...
Source: ClinicalTrials.gov - May 18, 2021 Category: Research Source Type: clinical trials

Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
Conditions:   Tuberculosis;   Tuberculosis, Pulmonary;   Bacterial Infections Respiratory;   Lung Diseases;   Mycobacterium Infections Intervention:   Drug: 500mg BTZ-043 containing 3.7 MBq of [14C]BTZ-043 Sponsors:   Michael Hoelscher;   Leibniz Institute for Natural Product Research and Infection Biology Hans Knöll Institut Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2021 Category: Research Source Type: clinical trials

Dried Blood Spot Test to Assess TB in Pregnancy
Condition:   Tuberculosis Interventions:   Diagnostic Test: 3G DBS;   Diagnostic Test: Sputum Test;   Diagnostic Test: 3G Veinous Blood Sponsors:   Institut Pasteur de Madagascar;   National Tuberculosis Program, Madagascar;   Analakely Hospital University Care and Public Health, Madagascar;   Virginia-Maryland College Veterinary Medecine, Blacksburg;   Johns Hopkins Bloomberg School of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2021 Category: Research Source Type: clinical trials

DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy)
Conditions:   Prostate Cancer;   Kidney Cancer;   Congenital Abnormality of Kidney;   Nephrolithiasis;   Kidney Tuberculosis;   Nephritis;   Kidney Injury;   Hydronephrosis Intervention:   Sponsor:   Aesculap AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 3, 2021 Category: Research Source Type: clinical trials

Study to Evaluate Safety, Tolerability, and the PK Profile of TBI-223 in Healthy Subjects
Conditions:   Tuberculosis;   Tuberculosis, Pulmonary Interventions:   Drug: 1800 mg TBI-223;   Drug: 2400mg TBI-223;   Drug: 3000mg TBI-223;   Drug: TBI-223 Placebo Sponsor:   Global Alliance for TB Drug Development Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 29, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB
Condition:   Tuberculosis, Pulmonary Intervention:   Drug: 4-month rifapentine-based regimen Sponsors:   Kaohsiung Veterans General Hospital.;   National Taiwan University;   Taipei Veterans General Hospital, Taiwan;   Chang Gung Memorial Hospital;   Centers for Disease Control, Taiwan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
Conditions:   Progressive Fibrosing Interstitial Lung Disease;   Lung Transplant;   Cystic Fibrosis;   Bronchiectasis;   Pulmonary Tuberculosis Intervention:   Device: ADAMM- RSM Device Sponsor:   University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials